Skip to content

News

Ernst Lengyel, MD, PhD, on Ovarian Cancer Research

Ernst Lengyel, MD, PhD, on Ovarian Cancer Research

Dr. Ernst Lengyel, as Associate Professor of Gynecologic Oncology at the University of Chicago, is a recipient of OCRF's Liz Tilberis Award. He was interviewed by OCRF's CEO Elizabeth Howard.

OCRF Research Shows Targeting Notch Pathway Helps Overcome ...

OCRF Research Shows Targeting Notch Pathway Helps Overcome Platinum Resistance

10/04/2012 OCRF Grantee Daniela Dinulescu, PhD Research funded by OCRF and published in the Sept. 27 edition of PNaS suggests that the Notch3 signaling pathway plays an important role in the maintenance of cancer stem cells (CSCs) and platinum resistance in ovarian cancer.  OCRF grantee Daniela Dinulescu, PhD of Brigham and Women’s Hospital in Boston, was the … Continued

Partner Member Profile: Ovarcome Non-Profit Inc.

Partner Member Profile: Ovarcome Non-Profit Inc.

One of the Ovarian Cancer National Alliance’s newest Partner Members, Ovarcome Non-Profit Inc., has made great strides in its first year. Founder and President Runsi Sen was inspired by her mother Atashi’s battle with ovarian cancer. Like many women, Atashi was diagnosed when her disease was already advanced, and she passed away within a year. … Continued

Intake Question Related to Ovarian Cancer Symptoms Can Help...

Intake Question Related to Ovarian Cancer Symptoms Can Help Women Get Diagnosed Sooner

According to a study done by the Fred Hutchison Cancer Cancer, a quick three-question survey as part of patient intake can help women with the symptoms of ovarian cancer be diagnosed with the disease sooner. The survey asks women if they have had abdominal/pelvic pain, feel full quickly when they eat and/or abdominal bloating. Women … Continued

New Study Finds Link Between Breast, Ovarian Cancers

New Study Finds Link Between Breast, Ovarian Cancers

09/25/2012 In a new study of 825 women published in the prestigious journal Nature, members of The Cancer Genome Atlas Network identified four major biological subtypes of breast cancer:  luminal A, luminal B, HER2 “enriched,” and basal-like. Basal-like tumors were found to be more like an aggressive form of ovarian cancer, high grade serous ovarian … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.